ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,513,000 | +5.0% | 89,692 | +21.6% | 0.24% | -11.4% |
| Q4 2021 | $6,202,000 | +16.9% | 73,756 | +25.4% | 0.27% | +5.0% |
| Q3 2021 | $5,306,000 | +93.8% | 58,829 | +104.9% | 0.26% | +103.1% |
| Q2 2021 | $2,738,000 | +60.8% | 28,711 | +92.0% | 0.13% | +23.1% |
| Q1 2021 | $1,703,000 | +106.9% | 14,955 | +151.5% | 0.10% | +55.2% |
| Q4 2020 | $823,000 | -70.6% | 5,947 | -82.5% | 0.07% | -72.7% |
| Q3 2020 | $2,798,000 | -6.1% | 34,049 | -10.7% | 0.24% | -28.4% |
| Q2 2020 | $2,981,000 | +11.8% | 38,108 | -36.5% | 0.34% | -42.3% |
| Q1 2020 | $2,667,000 | -53.3% | 60,033 | -55.1% | 0.59% | -0.7% |
| Q4 2019 | $5,706,000 | – | 133,601 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |